Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Incretin-lægemidler
Forsøgsevidens pr. lægemiddel, med data om ophør som markedsføring ofte undlader.
Established
Tirzepatide
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
Liraglutide
GLP-1 receptor agonist. Victoza, Saxenda
Established
Dulaglutide
GLP-1 receptor agonist. Trulicity
Promising
Oral semaglutide
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Compounded GLP-1 preparations
Unapproved compounded preparation. Various, unbranded
Relateret læsning
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Denne side blev automatisk oversat fra engelsk. Citaterne og tallene er uændrede. Læs den engelske original, hvis noget lyder underligt. Læs den engelske original